12 hasil untuk "Laura Labate"

Epidemiology, clinical overview, and potential risk of a new pandemic of measles virus

Matteo Bassetti; Daniele Roberto Giacobbe; Chiara Sepulcri dkk.

Infectious Diseases & Immunity, Vol. 5 No. 3 · 2025 · Inggris · DOAJ Scopus

Abstract. Measles outbreaks are increasingly being reported worldwide, posing a global health problem of pandemic potential. Europe was particularly affected in 2024, with a surge in cases linked to a decrease in herd immunity caused by reduced vaccination rates. COVID-19 has worsened the already…

Kaposi‐Juliusberg Varicelliform Eruption complicating Darier disease: May cannabinoid abuse be an underestimated risk factor?

Roberto Russo; Laura Labate; Emanuele Cozzani dkk.

Clinical Case Reports, Vol. 9 No. 8 · 2021 · Inggris · DOAJ Dikeluarkan Scopus 2021

Abstract Cannabinoid abuse may facilitate disseminated skin infection by herpes viruses in predisposed patients. These patients should be counselled about that.

Movimiento dentario ortondóntico hacia mesial en maxilar inferior de rata

Guido Lautaro Reboredo; William Eduardo Patitucci; Laura Labate dkk.

Odontoestomatología, Vol. 26 No. Supl. 1 · 2024 · Spanyol · DOAJ

Objetivo: Realizar un movimiento de ortodoncia que permita mesializar el primer molar inferior en rata Wistar. Materiales y métodos: Se utilizaron 6 ratas Wistar hembras de 30 días de edad (80±10 g). Bajo anestesia, se les colocó una banda de acero (0.9x2 mm) en el primer molar inferior izquierdo…

Safe Switch to an Oral Two‐Drug Regimen Based on Dolutegravir in People With Vertically Acquired HIV‐1: An Observational Multicenter Study

Giulia Meraviglia; Anna Sala; Francesco Bassani dkk.

Health Science Reports, Vol. 8 No. 7 · 2025 · Inggris · DOAJ Scopus

ABSTRACT Background and Aims People with vertically acquired HIV‐1 are exposed to antiretroviral drugs throughout their lives. Two‐drug regimens based on dolutegravir (DTG) are increasingly popular, showing excellent safety and efficacy and giving the opportunity to reduce toxicity and drug burden…

CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders

Lucia Taramasso; Laura Labate; Federica Briano dkk.

Frontiers in Virology, Vol. 2 · 2023 · Inggris · DOAJ Scopus

IntroductionDespite the high level of efficacy of modern antiretroviral therapy (ART) in reducing HIV viremia and the control of viral replication, some people living with HIV (PLWH) do not recover their CD4+ T cell count.MethodsTo evaluate the frequency and predictive factors of discordant immune…

Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA database

Laura Labate; Barbara Rossetti; Chiara Russo dkk.

Antiviral Therapy, Vol. 30 · 2025 · Inggris · DOAJ Scopus

Objective To explore the durability of multi-drug antiretroviral regimens in treatment-experienced PWH. Design This retrospective observational study including PWH who started mega-ART regimens between 1 January 2009 and 31 December 2019, selected from the ARCA cohort. Methods Time-dependent events…

Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series

Daniele Roberto Giacobbe; Laura Labate; Stefania Tutino dkk.

Annals of Medicine, Vol. 53 No. 1 · 2021 · Inggris · DOAJ Scopus

Background An unexpected high prevalence of enterococcal bloodstream infection (BSI) has been observed in critically ill patients with COVID-19 in the intensive care unit (ICU).Materials and methods The primary objective was to describe the characteristics of ICU-acquired enterococcal BSI in…

Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?

Laura Magnasco; Malgorzata Mikulska; Daniele Roberto Giacobbe dkk.

Microorganisms, Vol. 9 No. 1 · 2021 · Inggris · DOAJ Scopus

The possible negative impact of severe adult respiratory distress caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (COVID-19) on antimicrobial stewardship and infection control has been postulated, but few real-life data are available. The aim of this study was to…

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia

Malgorzata Mikulska; Laura Ambra Nicolini; Alessio Signori dkk.

PLOS ONE, Vol. 15 No. 8 · 2020 · Inggris · PLOS Scopus

Introduction: Coronavirus disease 2019 (COVID-19) can lead to respiratory failure due to severe immune response. Treatment targeting this immune response might be beneficial but there is limited evidence on its efficacy. The aim of this study was to determine if early treatment of patients with…

Juga tersedia di: DOAJ

Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study

Daniele Roberto Giacobbe; Laura Labate; Chiara Russo Artimagnella dkk.

Infectious Diseases and Therapy, Vol. 13 No. 9 · 2024 · Inggris · DOAJ Scopus

Abstract Introduction Cefiderocol is a siderophore cephalosporin showing activity against various carbapenem-resistant Gram-negative bacteria (CR-GNB). No data currently exist about real-world use of cefiderocol in terms of types of therapy (e.g., empirical or targeted, monotherapy or combined…

Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study)

Luigi Vetrugno; Nadia Castaldo; Alberto Fantin dkk.

Pulmonology, Vol. 29 No. 6 · 2023 · Inggris · DOAJ Scopus

Background The risk of barotrauma associated with different types of ventilatory support is unclear in COVID-19 patients. The primary aim of this study was to evaluate the effect of the different respiratory support strategies on barotrauma occurrence; we also sought to determine the frequency of…